Robert H. Zimmer
15Patents
4h-index
17Co-inventors
57Inventor score
Filing activity: Jan 6, 1998 → Jan 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6027748A | Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption | Human Necessities | 107 | Expired |
| US6221395A | Controlled release pharmaceutical tablets containing an active principle of low water solubility | Human Necessities | 41 | Expired |
| US7691807B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 5 | Expired |
| US8138145B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 4 | Active |
| US6908900B2 | COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL ACTIVITY THROUGH ORAL AND PARENTERAL ADMINISTRATION OF COMPOSITIONS COMPRISING POLYPEPTIDE DRUG SUBSTANCES AND OTHER POORLY ABSORBED ACTIVE INGREDIENTS | Human Necessities | 2 | Expired |
| US10398750B2 | Peptide-oligourea chimeric compounds and methods of their use | Human Necessities | 1 | Active |
| US7671029B2 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | Human Necessities | 1 | Expired |
| US9657072B2 | Modified peptides and their use for treating autoimmune diseases | Human Necessities | 0 | Active |
| US9487559B2 | Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans | Emerging Cross-Sectional Technologies | 0 | Active |
| US10889627B2 | Pro-drug peptide with improved pharmaceutical properties | Human Necessities | 0 | Active |
| US11285219B2 | Peptide-oligourea hybrid compounds | Human Necessities | 0 | Active |
| US10213482B2 | Methods of treating chronic inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US9243030B2 | Optically pure compounds for improved therapeutic efficiency | Human Necessities | 0 | Active |
| US11267861B2 | Peptide-oligourea foldamer compounds and methods of their use | Human Necessities | 0 | Active |
| US8080519B2 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.